腺氨酸激酶:一个表观遗传调节器和药物标
Uchenna Peter-Okaka1, Detlev Boison2,3,4
1Department of Neurosurgery, Rutgers New Jersey Medical School and Robert Wood Johnson Barnabas Health, New Brunswick, New Jersey, USA.
Journal of inherited metabolic disease
|May 20, 2025
概括
腺氨酸激酶 (ADK) 抑制剂通过调节腺水平来治疗神经和炎症状况具有前景. 新的研究突出了不同的ADK异型,提供了有针对性的治疗策略,潜在的副作用较少.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 腺酶激酶 (ADK) 是腺代谢中的一个关键酶,调节细胞腺水平.
- 抑制ADK会增加细胞外腺,激活治疗效果的腺受体.
- 之前的ADK抑制剂开发因不良事件而面临挑战,限制了治疗应用.
研究的目的:
- 审查最近在发现新型ADK抑制剂方面的进展.
- 探索ADK抑制剂在各种疾病中的治疗潜力.
- 讨论开发有针对性的ADK抑制剂的策略,以提高安全性.
主要方法:
- 关于ADK抑制剂的最近研究的文献综述.
- 对ADK异型 (ADK-S和ADK-L) 和它们的功能进行分析.
- 评估ADK的腺受体独立作用.
主要成果:
- 两个ADK异型,ADK-S (细胞质) 和ADK-L (核),表现出不同的功能.
- ADK-L通过腺受体独立的途径调节核甲基组.
- 新的ADK抑制剂正在开发中,重点是将核与细胞外腺功能分离.
结论:
- ADK-L代表了表观遗传调节的一个独特的治疗点.
- 下一代ADK抑制剂可能提供疾病修饰性质.
- 分离核和细胞外腺素功能的向疗法可以减少不良事件.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
cAMP-dependent Protein Kinase Pathways
6.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
RNA Editing
8.8K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.8K
Principles of Drug Action
5.7K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.7K


